05th week of 2011 patent applcation highlights part 48 |
Patent application number | Title | Published |
20110028316 | CARBON NANOTUBE BINDING PEPTIDES - Peptides have been generated that have binding affinity to carbon nanostructures and particularly carbon nanotubes. Peptides of or the invention are generally about twelve amino acids in length. Methods for generating carbon nanotube binding peptides are also disclosed. | 2011-02-03 |
20110028317 | Thermosensitive Recording Material - A proposed heat-sensitive recording material comprises a substrate, a heat-sensitive recording layer containing color formers and color acceptors, and a protective layer covering this heat-sensitive recording layer. The heat-sensitive recording layer has, as color acceptor, at least 66⅔ percent by weight of 4,4′-dihydroxydiphenyl sulfone based on the total percentage of color acceptors in the heat-sensitive recording layer, and the protective layer has, as binder, at least 60 percent by weight of diacetone-modified polyvinyl alcohol based on the total percentage of binder in the protective layer. | 2011-02-03 |
20110028318 | HERBICIDAL COMPOUNDS BASED ON N-AZINYL-N'-PYRIDYLSULPHONYLUREAS - There are described compounds of the formula (I) | 2011-02-03 |
20110028319 | FLORAL PRESERVATIVE - An electrochemically treated solution and method for cut flower and plant preservation, the solution having potassium, hypochlorous acid, and dissolved oxygen. | 2011-02-03 |
20110028320 | COMPOSITIONS AND METHODS FOR CONTROLLING NEMATODES - Compositions and processes for controlling nematodes are described herein, e.g., nematodes that infest plants or animals. The compounds include oxazoles, oxadiazoles and thiadiazoles. | 2011-02-03 |
20110028321 | METHOD AND BACTERIUM FOR PROMOTING THE GROWTH OF RACOMITRIUM CANESCENS AND SEED PLANTS - Disclosed are bacteria and methods for promoting growth of | 2011-02-03 |
20110028322 | HERBICIDE COMPOSITION AND WEED CONTROL METHOD - A herbicide composition including an oily extract as an active ingredient, which oily extract is obtained by cooling a steam containing volatile substances in a drying step of a lumber of trees belonging to the order Pinales, or by subjecting wood chips, sawdust or wood powder to hot water extraction or steam distillation. | 2011-02-03 |
20110028323 | Herbicidal Combination - A herbicidal suspension concentrate formulation comprising effective amount of glyphosate acid, effective amount of oryzalin and polyalkylene oxides and their copolymers such as EO/PO copolymer. Also disclosed is a process for the preparation of the herbicidal suspension concentrate formulations according to the present invention. | 2011-02-03 |
20110028324 | HERBICIDAL COMPOSITIONS - The present invention relates to a method of controlling weeds using mixtures of non-selective herbicides and plant growth regulators. It also relates to mixtures of non-selective herbicides and plant growth regulators per se, and compositions comprising the same. | 2011-02-03 |
20110028325 | Herbicidal Compositions Comprising Pyroxasulfone VI - The present invention relates to herbicidally active compositions, which comprise 3-[5-(difluoromethoxy)-1-methyl-3-(trifluoromethyl)pyrazol-4-ylmethylsulfonyl]-4,5-dihydro-5,5-dimethyl-1,2-oxazole [common name pyroxasulfone] and at least one herbicide B which is an inhibitor of the electron transfer in photosynthesis and which is selected from the groups of: b.1 arylurea herbicides; b.2 triazin(di)one herbicides; b.3 terbuthylazine; b.4 pyridazinone herbicides; b.5 phenylcarbamate herbicides; b.6 nitrile herbicides; b.7 bentazone and its salts such as bentazone sodium; and b.8 methylthiotriazine herbicides. The invention furthermore relates to the use of a composition as defined herein for controlling undesirable vegetation in crops which, by genetic engineering or by breeding, are resistant to one or more herbicides and/or pathogens, such as plant-pathogenous fungi, and/or to attack by insects; preferably resistant to one or more herbicides that act as inhibitor of the electron transfer in photosynthesis. The invention furthermore relates to a method for controlling undesirable vegetation, which comprises applying an herbicidal composition according to the present invention to the undesirable plants. Application can be done before, during and/or after, preferably during and/or after, the emergence of the undesirable plants. The herbicide A and the at least one herbicide B can be applied simultaneously or in succession. | 2011-02-03 |
20110028326 | COMPOSITIONS AND METHODS FOR PROVIDING PLANT GROWTH REGULATION - Compositions containing one or more plant growth regulators other than prohexadione calcium and one or more metal phosphites are suitable for providing growth regulation when applied to agricultural crops while providing micronutrients for plant health. | 2011-02-03 |
20110028327 | Superconducting Circuit, Production Method of Superconducting Joints, Superconducting Magnet, and Production Method of Superconducting Magnet - A superconducting circuit including a superconducting joint that joints a niobium titanium superconducting wire having a structure where a filament made of niobium titanium alloy is arranged in a matrix made of copper or copper alloy and other superconducting wire, in which a volume ratio or a surface density of an α-Ti precipitation in the niobium titanium alloy of the filament in the superconducting joint is smaller than the volume ratio or the surface density of the α-Ti precipitation in the niobium titanium alloy of the filament in the niobium titanium superconducting wire in a portion other than the superconducting joint. | 2011-02-03 |
20110028328 | Superconductive Article with Prefabricated Nanostructure for Improved Flux Pinning - A superconducting article comprises a substrate, a buffer layer overlying the substrate, and a high-temperature superconducting (HTS) layer overlying the buffer layer. The HTS layer includes a plurality of nanorods. A method of forming a superconducting article comprises providing a substrate, depositing a buffer layer overlying the substrate; forming a nanodot array overlying the buffer layer; depositing an array of nanorods nucleated on the nanodot array; and depositing a high-temperature superconducting (HTS) layer around the array of nanorods and overlying the buffer layer. | 2011-02-03 |
20110028329 | METHOD OF MAKING MATERIAL EXHIBITING SUPERCONDUCTIVITY CHARACTERISTICS - The invention herein is directed towards a method of making material exhibiting superconductivity characteristics which includes a laser processed region of a metal oxide crystal. The material has a transition temperature greater than a transition temperature of the metal oxide crystal, preferably greater than 140K. The transition temperature of the material may be considered greater than the transition temperature of the metal oxide crystal if the material has a transition temperature and the metal oxide crystal has no transition temperature. The present invention is also directed to a material which includes a laser processed strontium ruthenate crystal wherein the material has a greater oxygen content than the starting strontium ruthenate crystal. The present invention is also directed towards a method for manufacturing a material exhibiting superconductivity characteristics that includes providing a metal oxide crystal and laser ablating the metal oxide crystal and a material made by this process. | 2011-02-03 |
20110028330 | COMPOUNDS AND METHODS FOR THE LABELLING AND AFFINITY-SELECTION OF PROTEINS - The present invention relates to kits and methods for the isotopic/isobaric labeling and the subsequent affinity selection and analysis of proteinaceous molecules. In particular, the invention relates to a kit-of-parts comprising a combinatorial plurality of labeling reagent for the labeling of proteinaceous molecules, each labeling reagent comprising an isobaric label component, an isotopic label component, and a reactive group capable of reacting with a proteinaceous molecule, wherein the isotopic label component concomitantly is an affinity tag. The invention is also directed to a corresponding method for the analysis of proteinaceous molecules, comprising labeling at least one subset of the proteinaceous molecules present by employing a kit-of-parts as defined herein and subsequently separating the labeled molecules by affinity purification via the affinity tag comprised in the label. Finally, the invention relates to the uses of such methods for protein expression profiling or proteomic analyses. | 2011-02-03 |
20110028331 | DETECTION OF MUTATIONS IN ACTA2 AND MYH11 FOR ASSESSING RISK OF VASCULAR DISEASE - A method of detecting in an individual an increased risk of hyperplastic vasculomyopathy, or a vascular disease resulting therefrom is disclosed. The method comprises obtaining a DNA genome sample from the individual and detecting in the sample a missense mutation in a gene which is a component of a smooth muscle cell contractile unit. In some embodiments the gene is ACTA2 and in some embodiments the gene is MYH11. In some embodiments, the gene is sequenced and then compared to a panel of control gene sequences which are representative of the same gene in individuals without vascular disease or who are at low risk of developing hyperplastic vasculomyopathy, to detect any missense mutations in the gene. The presence of a missense mutation in the gene indicates an increased risk of hyperplastic vasculomyopathy. | 2011-02-03 |
20110028332 | MARKER FOR DIAGNOSIS OF BREAST CANCER, TEST METHOD, AND TEST KIT - An embodiment of the present invention provides a marker, a test method, and a test kit which can detect the onset of breast cancer that cannot be detected by palpation or mammography examination or breast cancer in an early stage (clinical stage 0), which are simple, and which have high reliability. | 2011-02-03 |
20110028333 | DIAGNOSING, PROGNOSING, AND EARLY DETECTION OF CANCERS BY DNA METHYLATION PROFILING - A method of employing DNA methylation analysis for the diagnosis, prognosis, and prediction of cancer. | 2011-02-03 |
20110028334 | CAPTURE PRIMERS AND CAPTURE SEQUENCE LINKED SOLID SUPPORTS FOR MOLECULAR DIAGNOSTIC TESTS - The present invention provides systems, methods, and compositions for performing molecular tests. In particular, the present invention provides methods, compositions and systems for generating target sequence-linked solid supports (e.g., beads) using a solid support linked to a plurality of capture sequences and capture primers composed of a 3′ target-specific portion and a 5′ capture sequence portion. In certain embodiments, the target sequence linked solid support is used in sequencing methods (e.g., pyrosequencing, zero-mode waveguide type sequencing, nanopore sequencing, etc.) to determine the sequence of the target sequence (e.g., in order to detect the identity of a target nucleic acid in sample). | 2011-02-03 |
20110028335 | Ligands For The GLP-1 Receptor And Methods For Discovery Thereof - Disclosed is the three-dimensional (3-D) structure of the GLP-1 receptor (GLP-1R) and methods by which the structure may be used to develop compounds that bind to, and/or modulate the GLP-1R. The technology described herein may be applied to the development of compounds that target the GLP-1R, or may be used to develop target compound that may bind to, and/or modulate the activity of the GLP-1R. | 2011-02-03 |
20110028336 | MIPOL1-ETV1 GENE REARRANGEMENTS - Compositions and methods associated with recurrent MIPOL1-ETV1 genetic rearrangements that are useful for cancer diagnosis and therapy are disclosed. | 2011-02-03 |
20110028337 | NUCLEOBASE CHARACTERISATION - The present invention provides modified nucleobase compounds, modified nucleic acid mimetic compounds and various uses thereof. In addition, the invention provides methods for nucleobase characterisation, SNP characterisation and nucleic acid sequencing. | 2011-02-03 |
20110028338 | SIGNATURES OF RADIATION RESPONSE - The present invention relates, in general, to gene expression profiles, and in particular, to a peripheral blood gene expression profile of an environmental exposure, ionizing radiation. The invention further relates to methods of screening patients for radiation exposure based on gene expression profiling and to kits suitable for use in such methods. | 2011-02-03 |
20110028339 | METHODS AND COMPOSITIONS RELATED TO MICROSCALE SAMPLE PROCESSING AND EVALUATION - Embodiments of the invention include gels and blots comprising electrophoretically separated samples amenable to scanning at 20 micron resolution and methods of using such compositions. | 2011-02-03 |
20110028340 | POLYNUCLEOTIDE ANALYSIS USING COMBINATORIAL PCR - The invention comprises a two-step process for analysis of polynucleotides by chain extension of multiple polynucleotide primers attached to solid supports by first performing PCR of the samples in the presence of multiple oligonucleotides in solution, the oligonucleotides of both sets being similar or identical. This produces immobilized single-strand polynucleotides containing genetic sequence data derived from sample molecules. In a second step, support-bound polynucleotides are interrogated by hybridization with a single labeled oligonucleotide probe or by second-strand synthesis with a primer-dependent polymerase using an oligonucleotide primer and nucleotide monomers, in which either or both of the primer and nucleotide monomers are labeled. Incorporation of label demonstrates the presence of two separate defined-sequence primers within the sample polynucleotide. The presence or absence within the sample of the multiple combinations of primers is demonstrable in a single experiment by use of suitable apparatus, such as an oligonucleotide array. | 2011-02-03 |
20110028341 | METHODS, DEVICES, AND SYSTEMS FOR CHEMILUMINESCENCE-BASED MICROFLUIDIC CELL COUNTING - A chemiluminescence-based detection system and method for counting blood cells by capturing and isolating target blood cells flowing through a microfluidic chip and detecting light emitted by the captured target blood cells. | 2011-02-03 |
20110028342 | Combinatorial Affinity Selection - In one aspect of the invention, methods for analyzing nucleic acid sample are provided. In a preferred embodiment, nucleic acids are selected using affinity matrices prior hybridization with a microarray. | 2011-02-03 |
20110028343 | Biomarkers of Ovarian Cancer - The invention is directed to assays for biomarkers associated with ovarian cancer that can be used diagnostically. It includes glass or plastic plates or slides on which the biomarkers have been immobilized and kits containing these plates or slides. | 2011-02-03 |
20110028344 | BIOMARKERS FOR ENDOMETRIAL DISEASE - This patent application discloses and describes a list of proteins that are found to be differentially expressed between normal endometrial epithelial cells and early stage cancerous endometrial epithelial cells. These proteins can be used either individually or in specific combinations in diagnostic and prognostic protein assays on various biological samples from endometrial cancer patients, or individuals suspected on having endometrial cancer. In addition, these proteins are also differentially expressed between normal endometrial epithelial cells and epithelial cells of other types of endometrial disease, and thus such diseases can be diagnosed using assays based on these proteins. The full length intact proteins can be assayed or peptides derived from these proteins can be assayed as reporters for these proteins. These proteins can also be identified as “companion diagnostic” proteins, wherein they are not only differentially expressed for use as diagnostic and prognostic indicators of endometrial cancer and other endometrial diseases, but the same proteins are also targets for therapeutic intervention of endometrial cancer and other endometrial diseases. | 2011-02-03 |
20110028345 | METHODS TO CHARACTERIZE CELL REPROGRAMMING AND USES THEREOF - Disclosed are label free biosensors and methods using these to observe stem cells and for the analysis of stem and related cells. | 2011-02-03 |
20110028346 | Photonic crystal microarray device for label-free multiple analyte sensing, biosensing and diagnostic assay chips - Methods and systems for label-free multiple analyte sensing, biosensing and diagnostic assay chips consisting of an array of photonic crystal microcavities along a single photonic crystal waveguide are disclosed. The invention comprises an on-chip integrated microarray device that enables detection and identification of multiple species to be performed simultaneously using optical techniques leading to a high throughput device for chemical sensing, biosensing and medical diagnostics. Other embodiments are described and claimed. | 2011-02-03 |
20110028347 | SUPPORT CARRYING AN IMMOBILIZED SELECTIVE BINDING SUBSTANCE - A support carrying an immobilized selective binding substance, that the support surface has a polymer containing the structural unit represented by the following General Formula (1) in an amount of 10% or more with respect all monomer units, and a selective binding substance is immobilized on the support surface by binding to the carboxyl group formed thereon via a covalent bond: | 2011-02-03 |
20110028348 | BINDING POLYPEPTIDES WITH OPTIMIZED SCAFFOLDS - The invention provides variant heavy chain variable domains (VH) with increased folding stability. Libraries comprising a plurality of these polypeptides are also provided. In addition, compositions and methods of generating and using these polypeptides and libraries are provided. | 2011-02-03 |
20110028349 | Endothelial monocyte activation polypeptide II, a biomarker for use in diagnosis and treatment of brain injury - A diagnostic tool and method of diagnosing brain injury and brain injury type (traumatic vs. ischemic) by detecting the level of expression of endothelial monocyte-activating polypeptide II (EMAP-II) and comparing to a control. An increase of EMAP-II indicates the presence of traumatic brain injury and a decrease of EMAP-II indicates the presence of ischemic brain injury. Detection of EMAP-II can be done in brain tissue, biofluids such as cerebrospinal fluid or blood (including plasma and serum) | 2011-02-03 |
20110028350 | PHOTOCLEAVABLE PROTECTING GROUPS - Novel compounds are provided, which are useful as linking groups in chemical synthesis, preferably in the solid phase synthesis of oligonucleotides and polypeptides. These compounds are generally photolabile and comprise protecting groups which can be removed by photolysis to unmask a reactive group. The protecting group has the general formula Y, wherein Y is a chemical structure as shown in FIG. | 2011-02-03 |
20110028351 | Methods and Devices for Immobilization of Single Particles - Disclosed herein are methods of immobilizing a particle which comprise focusing the flow of a sample fluid containing the particle into a virtual channel which flows towards an unoccupied hydrodynamic trap in a microfluidic channel such that the particle flows into the hydrodynamic trap and becomes immobilized therein. Also disclosed are microfluidic devices which comprise at least one microchannel having at least one hydrodynamic trap, at least one focusing fluid inlet, said focusing fluid inlet is upstream of the hydrodynamic trap such that a focusing fluid introduced therein results in a virtual channel of a sample fluid when present which preferentially flows toward the hydrodynamic trap. | 2011-02-03 |
20110028352 | HYBRIDIZATION DEVICE, METHODS, AND SYSTEM USING MIXING BEADS - A method, device and system for hybridizing a target oligonucleotide to at least one array comprising a plurality of mixing beads are provided. A target solution is mixed by agitating the mixing beads while the target oligonucleotides are hybridizing to the complementary probes on the array. In another embodiment, a permeable barrier contains the mixing beads, thereby preventing them from contacting the array surface. | 2011-02-03 |
20110028353 | BIOCHEMICAL REACTION CASSETTE - A biochemical reaction cassette having a structure for uniformizing a liquid flow in a reaction chamber with a simple additional arrangement is provided. A fluid resistive section is arranged in a channel that is constructed to include an injection port, a reaction chamber, and a discharge port. The fluid resistive section decreases the cross-sectional area of the channel to decrease the fluid resistance at ends in the width direction of the fluid resistive section and at positions remote from the injection port and the discharge port, where the flow rate is decreased. | 2011-02-03 |
20110028354 | Method of Stimulating Subterranean Formation Using Low pH Fluid Containing a Glycinate Salt - Hydraulic fracturing is conducted by use of a well treatment fluid which contains a guar gum derivative as viscosifying or gelling polymer, an organic zirconate complex of a zirconium metal and an alkanol amine as crosslinking agent and a salt of a hydroxylated glycine as crosslinking delaying agent. The fluid is characterized by a low pH, generally greater than or equal to 3.0 and less than or equal to 5.0. | 2011-02-03 |
20110028355 | Non-estrogenic alkylphenol derivatives - A method of making phenol and alkylphenol ethoxylates non-estrogenic by inserting 1 mole of propylene oxide onto the phenolic group before proceeding with the addition of ethylene oxide or mixtures of ethylene and propylene oxide. The final phenolic products can be further reacted to form sulfates, sulfonates, phosphate esters, condensed alkylphenol alkoxylates and other derivatives of alkylphenol or phenol. Non-estrogenic phenol and alkylphenol alkoxylates and their derivatives have been found to be excellent salt tolerant, high temperature stable surfactants for oil recovery from subterranean reservoirs. These products are also useful in forming emulsions of heavy crude for transportation through pipelines. | 2011-02-03 |
20110028356 | ANNULAR FLUIDS AND METHOD OF EMPLACING THE SAME - An annular fluid or packer fluid, and methods of making the same, that includes a water-miscible solvent, a viscosifying additive, a crosslinking agent, a crosslinking inhibitor having the facility to inhibit crosslinking between the viscosifying additive and the crosslinking agent, and an initiating agent having the facility to overcome an action of the crosslinking inhibitor and to initiate crosslinking between the viscosifying additive and the crosslinking agent, is shown and described. The fluid has a thermal conductivity of no more than about 0.25 btu/(hr·ft·° F.) and a potential to substantially increase its viscosity upon sitting for a selected period of time. | 2011-02-03 |
20110028357 | SYSTEM, METHOD AND APPARATUS FOR ENHANCING WELLBORE TREATMENT FLUID FLEXIBILITY - A method includes performing a chemical process to create a chemical product and an amount of heat, and transferring the heat to a first fluid. The method further includes hydrating a polymer in the first fluid, and adding the chemical product from the chemical process to the first fluid to create a treatment fluid. The method further includes diluting the treatment fluid with respect to at least one constituent of the treatment fluid. The method includes treating a formation of interest in a wellbore with the treatment fluid. The method includes changing a formulation of the treatment fluid during the treating. The method also includes extending the treating beyond a design amount, or ending the treatment before the design amount and preserving some reagents of the chemical process. | 2011-02-03 |
20110028358 | Methods of Fluid Loss Control and Fluid Diversion in Subterranean Formations - Improved methods of placing and/or diverting treatment fluids in subterranean formations are provided. In one embodiment, the methods comprise introducing a treatment fluid into a subterranean formation penetrated by a well bore, wherein the treatment fluid comprises: a base fluid, and a plurality of solid particulates comprising at least one selected from the group consisting of: a scale inhibitor, a chelating agent, and a combination thereof, wherein the solid particulates are substantially insoluble in the base fluid; and allowing at least a portion of the solid particulates to form a barrier or at partially divert a subsequent fluid. | 2011-02-03 |
20110028359 | METHOD AND COMPOSITION FOR ENHANCED HYDROCARBONS RECOVERY - A method of treating a hydrocarbon containing formation, comprising (a) providing a composition to at least a portion of the hydrocarbon containing formation, wherein the composition comprises a derivative selected from the group consisting of a carboxylate or a sulfate or glycerol sulfonate of an ethoxylated/propoxylated primary alcohol having a branched aliphatic group with an average carbon number from 10 to 24 and having an average number of branches per aliphatic group of from 0.7 to 2.5 and having at least 0.5 moles of propylene oxide per mole of primary alcohol and having at least 0.5 moles of ethylene oxide per mole of primary alcohol; and (b) allowing the composition to interact with hydrocarbons in the hydrocarbon containing formation. | 2011-02-03 |
20110028360 | ORGANIC CORROSION INHIBITOR PACKAGE FOR ORGANIC ACIDS - An acidizing composition useful for treating a subterranean hydrocarbon producing formation and removing scale from oilfield equipment, the composition including: an acid; water; and an effective amount of a corrosion inhibitor composition including: at least one mercapto-compound; and at least one alkoxylated acetylenic alcohol. Also disclosed are methods for removing scale from metal surfaces and for treating a subterranean hydrocarbon producing formation with such an acidizing composition whereby the corrosive effects of the acidizing composition on metal surfaces in contact therewith are reduced. | 2011-02-03 |
20110028361 | LOW-FRICTION SLIDING MECHANISM - A low-friction sliding mechanism includes first and second sliding members having respective sliding surfaces slidable relative to each other and a lubricant applied to the sliding surfaces of the first and second sliding members. At least the sliding surface of the first sliding member is made of a diamond-like carbon material, and at least the sliding surface of the second sliding member is made of either an aluminum-based alloy material, a magnesium-based alloy material or a diamond-like carbon material. The lubricant contains a base oil and at least one of an ashless fatty-ester friction modifier and an ashless aliphatic-amine friction modifier. | 2011-02-03 |
20110028362 | Automatic Transmission Fluid - Provided are compositions for use in Automatic Transmission Fluids. More specifically, provided are Automatic Transmission Fluids made using Gas-to-Liquids lubricant base oils, which are formulated with minimal to no polymeric Viscosity Index improvers and processes for production thereof. The automatic transmission fluids disclosed herein contain a) a lubricant base oil having a Viscosity Index greater than a Viscosity Index Factor as calculated by the following equation: | 2011-02-03 |
20110028363 | Liquid Extreme Pressure Additive - A liquid extreme pressure agent for use in lubricating compositions where the lubricating compositions comprise an oil of lubricating viscosity and the reaction product of: (a) a thiazole; (b) a composition comprising a carboxylic acid, a phosphorus containing acid or salt, or combinations thereof; and (c) an amine containing one or more branched hydrocarbyl groups. The invention also provides an additive composition comprising the reaction product described above and a process for making lubricating compositions, including greases, from the reaction product. | 2011-02-03 |
20110028364 | FRICTION MODIFIER AND TRANSMISSION OIL - A bis-type alkenyl-substituted succinimide which is prepared by reaction of succinic anhydride substituted with 2-alkenyl group having a branch structure in β-position with alkylenepolyamine and its derivatives derived from the bis-type alkenyl-substituted succinimide by post-treatment are of value as friction modifiers, particularly for incorporation into lubricating oils for automatic transmissions. | 2011-02-03 |
20110028365 | ANTI-WEAR ADDITIVE COMPOSITION AND LUBRICATING OIL COMPOSITION CONTAINING THE SAME - An anti-wear additive composition comprising at least one acid phosphite compound and at least one neutral phosphite compound, wherein the ratio of the acid phosphite to the neutral phosphite is from about 1.0:10.7 to about 2.0:1.0, and lubricating oil compositions containing the same. | 2011-02-03 |
20110028366 | FUNCTIONAL SUBSTANCE-RELEASING AGENT - Disclosed are: a functional material release agent including 35% to 95% by mass of the silicate ester compound represented by formula (1) and 0% to 40% by mass of the silicate ester compound represented by formula (2); a method for manufacturing the release agent; and compositions containing the release agent. (In the formula, R | 2011-02-03 |
20110028367 | PHOTO-LABILE PRO-FRAGRANCE CONJUGATES - The present invention relates to photo-labile pro-fragrance conjugates comprising:
| 2011-02-03 |
20110028368 | HYPOCHLORITE DENTURE COMPOSITIONS AND METHODS OF USE - A solid composition including calcium and/or magnesium hypochlorite, a builder (e.g., one or more of carbonate, bicarbonate, sesquicarbonate), an acid, a water-soluble polymer, at least one anionic surfactant, and optionally, a hydrotrope. The composition does not include any potassium hypochlorite, sodium hypochlorite, lithium hypochlorite, N-halogenated compounds, peroxides, persulfates, hydantoins, isocyanurates, or carboxylic acids that also have hydroxyl, amino, amido, imino, or imido groups. Upon dissolution of the composition in water, the calcium and/or magnesium hypochlorite and acid react to form hypochlorous acid. The use of hypochlorous acid, rather than direct use of an alkaline or alkaline earth hypochlorite results in a composition that is typically acidic rather than basic, and that results in improved cleaning The composition is particularly suited for cleaning and disinfecting dentures. | 2011-02-03 |
20110028369 | Environmentally Acceptable Acidic Lavatory Treatment Compositions - Aqueous, thickened, acidic compositions which exhibit a pH of about (7) or less preferably (5) or less, and comprise an organic acid constituent selected from formic acid, citric acid and oxalic acid, a thickening constituent or constituents based on one or more gums, particularly xanthan gum which form a thickener system in the inventive composition, and at least one detersive surfactant based on glycoside surfactants, water in an amount of at least 85% wt, preferably at least about 90% wt, and one or more further optional constituents, wherein the compositions exclude: (a) surfactant compounds which include a nitrogen atom in the surfactant compound, and (b) inorganic acids. | 2011-02-03 |
20110028370 | CLEANER CONCENTRATES, ASSOCIATED CLEANERS, AND ASSOCIATED METHODS - Cleaner concentrates, associated cleaners, and associated methods are disclosed. The cleaner concentrates are capable for use in making cleaners that are capable of removing from surfaces fresh, greasy soils and polymerized soils more recently encountered in the food service industry originating from non-trans-fat oils. The cleaner concentrates include one or more alkalinity sources, one or more chelants, one or more surfactants, and as a remainder, water. The one or more alkalinity sources may be present in an amount sufficient to provide a free alkalinity (expressible as Na | 2011-02-03 |
20110028371 | HYBRID COPOLYMERS - Hybrid copolymers include a synthetic polymer which is derived from at least one anionic or non-anionic ethylenically unsaturated monomer and a naturally derived hydroxyl containing chain transfer agent as an end group. The hybrid copolymer may be prepared as a blend with a builder or a chelating agent. Hybrid copolymers also include a synthetic portion derived from at least one ester monomer and a naturally derived hydroxyl containing chain transfer agent as an end group. Ester graft copolymers include a naturally derived hydroxyl moiety backbone and side chains derived from at least one ester monomer. Further, a method of determining the concentration of a hybrid copolymer in an aqueous system and methods of preparing a hybrid copolymer are also included. | 2011-02-03 |
20110028372 | Triggered Release System - The combination of an enzyme substrate and an enzyme capable of accelerating the modification of said substrate, provides a triggered release system which works especially well. The use of the enzyme-triggered release system can retain a rinse benefit agent during the wash stage and release it during the subsequent rinse stage. | 2011-02-03 |
20110028373 | HAND DISH COMPOSITION IN THE FORM OF AN ARTICLE - Hand dish compositions such as those that are typically provided to the consumer in liquid form are disclosed. The hand dish composition is in the form of a flexible, porous, dissolvable substrate. The substrate may comprise hand care compositions. The article may take any number of suitable shapes. | 2011-02-03 |
20110028374 | LAUNDRY DETERGENT COMPOSITIONS IN THE FORM OF AN ARTICLE - A laundry additive article comprises surfactant, water-soluble and/or water-dispersible film-forming polymer, plasticizer, bleach, suds suppressor and Remaining Water. The article is in the form of a first flexible porous dissolvable solid structure having a dry density and having a Percent open cell content. | 2011-02-03 |
20110028375 | Fungal serine protease and use thereof - The present invention is related to a fungal serine protease enzyme, which comprises an amino acid sequence the mature Fa_RF7182 enzyme having an amino acid sequence of SEQ ID NO: 18. The serine protease is obtainable from | 2011-02-03 |
20110028376 | PROCESS FOR PROTECTING THE COLORS OF COLORED TEXTILE ARTICLES OR FOR PROVIDING CREASE RESISTANCE TO TEXTILE ARTICLES - The invention concerns a composition for cotton textile care in particular, comprising an anionic polysaccharide (in particular anionic polygalactomannan) having a mole weight higher than 250000. The composition can be a solid or liquid detergent formulation, a liquid rinsing and/or softening formulation, a drying additive contacted with wet textile in a dry textile, an aqueous ironing formulation, a prespotting washing additive deposited on the textile before a washing operation. | 2011-02-03 |
20110028377 | Color-Protecting Detergent or Cleanser - Color protection of detergents and cleansers when used for washing or cleaning colored textile fabrics. This is accomplished by use of particulate polymers in the detergent or cleanser. | 2011-02-03 |
20110028378 | Protease Variants and Compositions - The present invention relates to enzymes produced by mutating the genes for a number of subtilases and expressing the mutated genes in suitable hosts are presented. The enzymes exhibit improved wash performance in any detergent in comparison to their wild type parent enzymes. | 2011-02-03 |
20110028379 | METHOD FOR A CLEANER USING SILICIC ACID-NATRIUM - Disclosed is a method for preparing a cleaner containing silicate (64-75% SiO | 2011-02-03 |
20110028380 | Fabric Conditioning Fabric Care Articles Comprising a Particulate Lubricant Agent - A fabric conditioning articles containing a particulate lubricant agent comprising a platelet which is optionally hexagonal in shape, said platelet optionally having a planar aspect ratio of particle size to thickness of from about 50 to about 300. Non-limiting examples of suitable particulate lubricant agents can include materials such as a boron nitride, a tungsten disulfide, a molybdenum disulfide, a polytetrafluorethylene (PTFE), a talc, a calcium fluoride, a cerium fluoride and a tungsten disulfide, and a mixture thereof. | 2011-02-03 |
20110028381 | Low Solids, High Viscosity Fabric Softener Compositions and Process for Making the Same - Disclosed are low solids and high viscosity fabric softener compositions and processes for preparing them. The composition contains from about 0.05% to about 10% by weight of a rheology modifying fabric softening active comprising at least one long chain amine of the present technology, a derivative thereof, or a mixture thereof, and from about 1% to 10% by weight of an additional fabric softening active dispersed in water. | 2011-02-03 |
20110028382 | TREATMENT OF ORAL PHARYNGEAL DYSPHAGIA - The invention provides compounds for use in a method of treating oral pharyngeal dysphagia in an individual and related products. One embodiment of the invention comprises administering to an individual an effective amount of a vanilloid receptor 1 (VR-1) agonist or high-affinity partial agonist to promote a swallow reflex. | 2011-02-03 |
20110028383 | Activated Forms Of Notch And Methods Based Thereon - The present invention is directed to methods for detecting or measuring Notch activation by observing or measuring the appearance of Notch on the cell surface or by observing or measuring Notch cleavage products that are indicative of Notch activation. The present invention is also directed to methods for detecting a molecule that modulates Notch activation by observing or measuring a change in the amount of Notch expressed on the cell surface or a change in the amount or pattern of Notch cleavage products. The present invention is also directed to a substantially purified activated heterodimeric form of Notch and components thereof and pharmaceutical compositions and kits thereof. The present invention is based, at least in part, on the discovery that Notch in its active form, i.e., the form that mediates signal transduction and that binds Notch ligands such as Delta, is a heterodimer of an about 180 kDa subunit (N | 2011-02-03 |
20110028384 | RAP VARIANTS FOR DRUG DELIVERY - The present invention relates to stabilized RAP variants and methods of use thereof. Conjugates of stabilized RAP variants to therapeutic compounds and stabilized RAP fusion proteins comprising therapeutic polypeptides are also presented. | 2011-02-03 |
20110028385 | Combination of Immunomodulator and Anti-Pathogenic Agent - A compound comprising combination of an immunomodulator and to at least one anti-pathogenic agent for treating of facultative or strict infections caused by intracellular microorganisms, the components of the combination or association of substances of the invention, the immunomodulator (proteic aggregate of ammonium and magnesium phospholinoleate-palmitoleate anhydride) and at least one substance with antimicrobial properties can be administered either jointly, simultaneously, consecutively or sequentially, in an appropriate form, according to their chemical properties, and in a dose effective against microorganisms in human and animals. | 2011-02-03 |
20110028386 | Antimicrobial Peptides - Disclosed are antimicrobial peptides with useful or superior properties such as antimicrobial activity, desirable levels of hemolysis, and advantageous therapeutic index against various microorganisms, especially | 2011-02-03 |
20110028387 | METHODS OF SCREENING OF PP1-INTERACTING POLYPEPTIDES OR PROTEINS, PEPTIDES INHIBITING PP1c BINDING TO Bcl-2 PROTEINS, BCL-XL AND BCL-W, AND USES THEREOF - The invention relates to methods for identifying novel PP1-interacting polypeptides and proteins, compounds which are able to inhibit the binding of PP1c to certain factors naturally interacting with it, especially proteins of the Bcl-2 family (such as Bcl-x | 2011-02-03 |
20110028388 | DOUBLE-STRANDED POLYETHYLENE GLYCOL MODIFIED GROWTH HORMONE, PREPARATION METHOD AND APPLICATION THEREOF - The growth hormone with high biological activity modified by the double-stranded polyethylene glycol at a single site and the preparation method thereof are provided. The PEGylated growth hormone has a higher biological activity and a longer half-life than the unmodified growth hormone. The composition comprising the PEGylated growth hormone is useful in the treatment of the growth or development disorder such as growth hormone deficiency, Turner syndrome etc. | 2011-02-03 |
20110028389 | USE OF INFANT FORMULA WITH REDUCED PROTEIN CONTENT - A method of continuously reducing the circulating level of insulin like growth factor 1 (IGF-1) in the first few months of the life of an infant comprises administering to the 5 infant a nutritional composition comprising proteins in an amount such that the composition contains less than 2.25 g of protein per 100 kcal. As IGF-1 is known to be a key control point in nutritional regulation of growth, this may offer a method of reducing the risk of developing obesity in later life. | 2011-02-03 |
20110028390 | Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors - The invention provides compounds of Formula (1) or a pharmaceutically acceptable salt of said compound, wherein R | 2011-02-03 |
20110028391 | Use of GLP-1 Peptides - GLP-1(1-45) or a fragment or an analogue thereof can be used in the preparation of a medicament for peripheral administration in the suppression of appetite or induction of satiety. | 2011-02-03 |
20110028392 | METHODS FOR USE OF BRANCHED AMINO ACIDS - The invention provides an orally-administrable nutritional product comprising a dipeptide including a branched chain amino acids (BCAA). In one embodiment, the nutritional product comprises a dipeptide selected from at least one of the following: alanyl-leucine, alanyl-isoleucine, alanyl-valine, glycyl-leucine, glycyl-isoleucine, and glycyl-valine. | 2011-02-03 |
20110028393 | FLOWABLE PASTE AND PUTTY BONE VOID FILLER - The present invention provides a composition that may be used as an implant or a bone graft substitute or extender for filling voids and/or promoting fusion of osseous tissues. The implant may comprise ceramic granules such as calcium phosphate granules and one or more polysaccharide excipients, and may be in the form of a putty or flowable paste. Optionally, the implant may also comprise a growth factor such as a bone morphogenetic protein. | 2011-02-03 |
20110028394 | THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS - Compounds having activity for lowering parathyroid hormone levels are described. In one embodiment, the compounds are comprised of a contiguous sequence of subunits, X | 2011-02-03 |
20110028395 | PEPTIDE MODULATORS OF ANGIOGENESIS AND USE THEREOF - The invention generally features compositions and methods that are useful for modulating blood vessel formation, as well as methods that provide for the systematic and efficient identification of angiogenesis modulators. As described in more detail below, a systematic computational methodology based on bioinformatics was used to identify novel peptide modulators of angiogenesis that have been characterized in vitro and/or in vivo. | 2011-02-03 |
20110028396 | MEDICAL COMPOSITION - It is an object of the present invention to attach a biopolymer composition to a synthetic polymer substrate without the use of a toxic adhesive. The present invention provides a medical composition, wherein a synthetic polymer substrate and a composition mainly composed of a biopolymer directly adhere to each other due to dissolution of the surfaces thereof. | 2011-02-03 |
20110028397 | Use of Urokinase Type Plasminogen Activator Inhibitors for the Treatment of Corneal Disorders - The invention concerns the use of inhibitors of the urokinase type of plasminogen activator (uPA) appearing in the anterior segment of the eye, for the treatment and prevention of corneal ulcers and other disorders. The invention further concerns pharmaceutical compositions, comprising inhibitors of uPA, preferably eye drops and eye ointments. The pharmaceutical compositions according to the invention preferably comprise PAI-2 protein or a derivative thereof retaining uPA-inhibiting capacity, or a tripeptide aldehyde inhibitor, preferably the D-Phe-Pro-Arg-aldehyde (Ald-1). The PAI-2 protein, used according to the invention, is preferably produced through bacterial expression, as a fusion protein. | 2011-02-03 |
20110028398 | METHODS FOR TREATING AND LIMITING FIBROTIC DISORDERS AND KELOIDS - The present invention provides methods for treating and/or limiting fibrotic disorders and/or treating or limiting scars selected from the group consisting of keloids and hypertrophic scars comprising administering to an individual in need thereof an amount effective to treat and/or limit scars selected from the group consisting of keloids and hypertrophic scars of a polypeptide comprising an HSP20-related polypeptide. | 2011-02-03 |
20110028399 | CITRULLINATED CYTOKINES - The present invention provides natural occurring, recombinant and synthetic chemokines, interleukins and cytokines in which at least one arginine residue is replaced by or modified into a cltrulline residue. The present Invention also relates to the use of said chemokines, interleukins or cytokines and pharmaceutical compositions comprising said chemokines, interleukins or cytokines as anti-inflammatory agents and as haematopoietic cell (including stem-cell, progenitor cell and leukocyte) or endothelial cell mobilizing agents. Furthermore, the present invention relates to the use of said chemokines, interleukins or cytokines to create antibodies and to use said chemokines, interleukins, cytokines and/or said antibodies as diagnostic tools and as a medicine. In addition, the present invention provides for the processes for the identification and production of the citrullinated chemokines, interleukins or cytokines of the invention. | 2011-02-03 |
20110028400 | SULFATED UNSATURATED DISACCHARIDIC CHONDROITIN SULFATE IN CONNECTIVE TISSUE PROTECTION AND REPAIR - The present invention generally relates to the protection and repair of connective tissues. In particular, the present invention relates to the use of chondroitin sulfates and its derivatives in connective tissue protection and repair. The present inventors have found that unsaturated disaccharidic chondroitin sulfate can be used for the preparation of a composition to develop, protect and/or repair connective tissues. This allows it for example to treat or prevent osteoarthritis or rheumatoid arthritis, and/or the symptoms thereof as well as to treat or prevent signs of skin ageing such as the appearance of wrinkles effectively. | 2011-02-03 |
20110028401 | CRIPTO BLOCKING MOLECULES AND THERAPEUTIC USES THEREOF - The present invention concerns a monomeric or multimeric tripeptide molecule able of inhibiting Cripto signalling in embryonic stem cells, thereby enhancing dopamine specification and differentiation, after transplantation in animal models of Parkinson's disease, as well as reducing tumor formation, and uses thereof. | 2011-02-03 |
20110028402 | SUBSTANCE P-SAPORIN (SP-SAP) CONJUGATES AND METHODS OF USE - This invention provides a conjugate comprising Substance P, or an analog thereof, and a protein, such as Saporin, that inhibits protein synthesis. | 2011-02-03 |
20110028403 | HSP70-Based Treatment for Autoimmune Diseases and Cancer - A non-natural HSP70 activating region that activates dendritic cells. Polypeptides that bind to the HSP70 activating region can be used to treat autoimmune diseases, such as vitiligo, by binding to HSP70 and preventing HSP70 form activating dendritic cells. The HSP70 binders can be constructed in the form of fusions proteins with a trimerizing structural element that may associate to form a trimeric complex. Pharmaceutical compositions and methods for treating vitiligo using the HSP70 binding proteins, fusion proteins and complexes. | 2011-02-03 |
20110028404 | Composition Comprising Vegetable Peptone for Promoting Stem Cell Proliferation - The present invention relates to a composition for promoting stem cell proliferation which contains a vegetable peptone. More specifically, this invention relates to: a serum-free composition for culturing stem cells which contains a vegetable peptone; a composition for improving skin condition containing the vegetable peptone as an active ingredient; and a composition for improving skin condition containing a culture medium as an active ingredient in which cultured stem cells are removed after being cultured in a serum-free composition medium for stem cell culture containing the vegetable peptone. Since the disclosed serum-free composition for culturing stem cells does not need the use of expensive animal serum, the manufacturing cost can be remarkably lowered. Also the use of anima serum in the medium can basically prevent contamination material caused by the use of animal serum. In addition, the disclosed composition containing the vegetable peptone and the medium in which the stem cells are cultured in the serum-free medium both serve to promote and activated the proliferation of stem cells, and improve various skin conditions. | 2011-02-03 |
20110028405 | SULFAMIDES AS ZAP-70 INHIBITORS - The invention relates to compounds of formula (I) | 2011-02-03 |
20110028406 | Pharmaceutical Compositions Comprising A Cyclosporin, A Hydrophilic Surfactant and a Lipophilic Surfactant - Pharmaceutical compositions, which enable high absorption when administered orally, and which comprise a cyclosporin or cyclosporin derivative dissolved in a solvent-surfactant system further comprising a hydrophilic surfactant and a lipophilic surfactant, with minimal quantities of solvents. | 2011-02-03 |
20110028407 | ENHANCEMENT OF INNATE RESISTANCE TO INFECTION - The present invention provides compounds and compositions that enhance the innate immune system. The present invention comprises methods of preventing, treating or ameliorating an infectious disease comprising administering said compounds to a subject. The invention also comprises methods of formulation and administration of said compounds. | 2011-02-03 |
20110028408 | DIAGNOSTIC MOLECULE AND THERAPEUTIC TARGET - Provided herein are methods and compositions for regulating airway tissue remodelling and for treating or preventing conditions associated with airway inflammation and/or airway tissue remodelling. The methods comprise normalising fibulin-1 levels in said tissue relative to normal endogenous levels. In an embodiment the methods comprise administering to a subject in need thereof an effective amount of at least one agent capable of inhibiting the expression and/or activity of fibulin-1. | 2011-02-03 |
20110028409 | DETECTION OF ANTI-RIBOSOMAL P PROTEIN ANTIBODIES BY MEANS OF SYNTHETIC PEPTIDES - The present invention refers peptides and methods for the identification of diagnostic antibodies in auto-immune diseases such as Systemic Lupus Erythematosus (SLE), and therefore useful tools for diagnosis or therapeutic treatment of SLE. | 2011-02-03 |
20110028410 | Use of Amygdalin Analogues for the Treatment of Psoriasis - The compounds of formula (1), wherein n is an integer from 0 to 4; R1 is a radical selected from the group consisting of H, CH | 2011-02-03 |
20110028411 | ALPHA-GALACTOCERAMIDE ANALOGS, THEIR METHODS OF MANUFACTURE, INTERMEDIATE COMPOUNDS USEFUL IN THESE METHODS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - The invention relates to α-galactoceramide analogs, their methods of manufacture, intermediate compounds useful in these methods. It also relates to pharmaceutical compositions containing the α-galactoceramide analogs. The methods of manufacture of the invention involve the use of unsaturated intermediate compounds which enable to synthesize α-galactoceramide analogs by a mere metathesis reaction. The α-galactoceramide analogs of the invention are useful as active ingredients of pharmaceutical compositions, particularly in pharmaceutical compositions having anti-cancerous properties. | 2011-02-03 |
20110028412 | Herbal enhanced analgesic formulations - The analgesic properties of L-tryptophan and 5-HTP can be safely enhanced with the coadministration of salacin. Salacin can be effectively provided in the form of white willow bark along with other ingredients to further enhance the formulation's analgesic effect. As salacin can cause the loss of vitamin C in humans, the formulation advantageously includes a supplemental amount of vitamin C. | 2011-02-03 |
20110028413 | Methods of Reducing Methotrexate Nephrotoxicity - The present invention provides compositions and methods to reduce renal damage caused by nephrotoxic drugs such as methotrexate. The invention provides compositions comprising a substituted cyclodextrin, methotrexate and a pharmaceutically acceptable carrier, where the cyclodextrin is present in an amount effective for substantially inhibiting the nephrotoxic effect of the methotrexate. | 2011-02-03 |
20110028414 | GLUCOPYRANOSIDE DERIVATIVES - Novel compounds of the formula (I), in which X has the meaning indicated in Patent Claim | 2011-02-03 |
20110028415 | USE OF 3-(INDOLYL)- OR 3-(AZAINDOLYL)-4-ARYLMALEIMIDE DERIVATIVES IN LEUKENIA MANAGEMENT - The present invention relates to the use of a compound of formula (I) wherein R | 2011-02-03 |